WSTAM
CLLS

Wilbanks Smith & Thomas Asset Management’s Cellectis CLLS Stock Holding History

Wilbanks Smith & Thomas Asset Management’s Portfolio CLLS Stock Details CLLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-50
Closed -$1K – 518
2018
Q3 		$1K Buy
+50
New +$1.44K ﹤0.01% 1499

Other funds holding CLLS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wilbanks Smith & Thomas Asset Management's CLLS Position: Q4 2018 in Review

Wilbanks Smith & Thomas Asset Management sold out of Cellectis (CLLS) in Q4 2018, closing a stake of 50 shares — an estimated $1K sold.

Wilbanks Smith & Thomas Asset Management first reported a position in CLLS in Q3 2018 and held it in 1 quarter. The position peaked at $1K in Q3 2018. 65 funds tracked by Wall St. Rank hold CLLS as of Q4 2018.

  • Wilbanks Smith & Thomas Asset Management reported no remaining Cellectis position as of Q4 2018 after selling out during the quarter.
  • Wilbanks Smith & Thomas Asset Management sold 50 Cellectis shares in Q4 2018, an estimated $1K.
  • Wilbanks Smith & Thomas Asset Management first reported a position in Cellectis in Q3 2018 and held it in 1 quarter.
  • Wilbanks Smith & Thomas Asset Management's Cellectis position peaked at $1K in Q3 2018.
  • 65 funds tracked by Wall St. Rank held Cellectis as of Q4 2018.

Based on Wilbanks Smith & Thomas Asset Management's 13F filing for Q4 2018, filed 8 Feb 2019.